Tonix Pharma(DE:TPM0)
€3.35-0.21 (-5.85%)
DE:TPM0
Tonix Pharma earnings date
€3.35
At close:-0.21 (-5.85%)
Tonix Pharma (TPM0) Q2 2021 Earnings Report
9 Followers
DE:TPM0 Q2 2021 EPS Results
- Actual EPS
- -EUR 40,372.84
- Consensus EPS
- -EUR 37,489.06
- Beat/Miss
- Missed by -EUR 2,883.77
- One Year Ago EPS
- -EUR 132,653.60
DE:TPM0 Q2 2021 Revenue Results
- Actual Revenue
- EUR 0
- Expected Revenue
- EUR 0
- Beat/Miss
- Met expectations
- YoY Revenue Growth
- ―
Earnings Announcement Details
- Quarter
- Q2 2021
- Date
- 08/09/2021
- Time
- After Close
- Conference Call
- Monday, August 9, 2021
DE:TPM0 Upcoming Earnings
Tonix Pharma's next earnings date is estimated for March 15, 2027, based on past reporting schedules.
Q2 2021 Earnings Call Audio
No earnings call audio is available for this earnings event.
Q2 2021 Earnings Slide Deck
No slide deck is available for this earnings event.
Q2 2021 Earnings Call Summary
No earnings call summary is available for this earnings event.
DE:TPM0 Earnings History
| Report Date | Fiscal Quarter | Forecast / EPS | Last Year's EPS | EPS YoY Change | Press Release |
|---|---|---|---|---|---|
| Mar 15, 2027 | 2026 (Q4) | -2.23- | -3.59 | ― | ― |
| Nov 09, 2026 | 2026 (Q3) | -2.15-2.60 | -3.24 | 19.50% (+0.63) | |
| Aug 10, 2026 | 2026 (Q2) | -2.38-2.20 | -3.48 | 36.79% (+1.28) | |
| May 11, 2026 | 2026 (Q1) | -2.32-2.64 | -2.56 | -3.17% (-0.08) | |
| Mar 12, 2026 | 2025 (Q4) | -2.87-3.59 | -8.8 | 59.26% (+5.22) | |
| Nov 10, 2025 | 2025 (Q3) | -3.23-3.24 | -20.73 | 84.39% (+17.49) | |
| Aug 11, 2025 | 2025 (Q2) | -2.50-3.48 | -1737.47 | 99.80% (+1734.00) | |
| May 12, 2025 | 2025 (Q1) | -2.78-2.56 | -519.08 | 99.51% (+516.52) | |
| Mar 18, 2025 | 2024 (Q4) | -16.67-8.80 | -19753.85 | 99.96% (+19745.05) | |
| Nov 12, 2024 | 2024 (Q3) | -349.66-20.73 | -5277.31 | 99.61% (+5256.58) |
The table shows recent earnings report dates and whether the forecast was beat or missed. See the change in forecast and EPS from the previous year.
Beat Missed
